tegaserod
Selected indexed studies
- Tegaserod for the Treatment of Irritable Bowel Syndrome. (Antiinflamm Antiallergy Agents Med Chem, 2020) [PMID:31518227]
- Tegaserod: What's Old Is New Again. (Clin Gastroenterol Hepatol, 2022) [PMID:35123085]
- Tegaserod. (, 2006) [PMID:33104316]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tegaserod for the Treatment of Irritable Bowel Syndrome. (2020) pubmed
- Tegaserod: What's Old Is New Again. (2022) pubmed
- Tegaserod. (2006) pubmed
- Tegaserod. (1999) pubmed
- Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. (2021) pubmed
- Tegaserod for the treatment of irritable bowel syndrome. (2004) pubmed
- Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data. (2022) pubmed
- Tegaserod Stimulates 5-HT(4) Serotonin Receptors in the Isolated Human Atrium. (2024) pubmed
- Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway. (2025) pubmed
- Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. (2007) pubmed